Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis
- PMID: 19130260
- DOI: 10.1007/s10534-008-9197-9
Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis
Abstract
The bacterium Pseudomonas aeruginosa is commonly isolated from the general environment and also infects the lungs of patients with cystic fibrosis (CF). Iron in mammals is not freely available to infecting pathogens although significant amounts of extracellular iron are available in the sputum that occurs in the lungs of CF patients. P. aeruginosa has a large number of systems to acquire this essential nutrient and many of these systems have been characterised in the laboratory. However, which iron acquisition systems are active in CF is not well understood. Here we review recent research that sheds light on how P. aeruginosa obtains iron in the lungs of CF patients.
Similar articles
-
Pseudomonas siderophores in the sputum of patients with cystic fibrosis.Biometals. 2011 Dec;24(6):1059-67. doi: 10.1007/s10534-011-9464-z. Epub 2011 Jun 4. Biometals. 2011. PMID: 21643731
-
Proteomics of Pseudomonas aeruginosa Australian epidemic strain 1 (AES-1) cultured under conditions mimicking the cystic fibrosis lung reveals increased iron acquisition via the siderophore pyochelin.J Proteome Res. 2012 Feb 3;11(2):776-95. doi: 10.1021/pr200659h. Epub 2011 Dec 13. J Proteome Res. 2012. PMID: 22054071
-
Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis.Mol Microbiol. 2005 Apr;56(2):309-22. doi: 10.1111/j.1365-2958.2005.04552.x. Mol Microbiol. 2005. PMID: 15813726 Review.
-
An intragenic deletion in pilQ leads to nonpiliation of a Pseudomonas aeruginosa strain isolated from cystic fibrosis lung.FEMS Microbiol Lett. 2007 May;270(2):201-6. doi: 10.1111/j.1574-6968.2007.00664.x. Epub 2007 Feb 16. FEMS Microbiol Lett. 2007. PMID: 17302936
-
Oxygen, cyanide and energy generation in the cystic fibrosis pathogen Pseudomonas aeruginosa.Adv Microb Physiol. 2007;52:1-71. doi: 10.1016/S0065-2911(06)52001-6. Adv Microb Physiol. 2007. PMID: 17027370 Review.
Cited by
-
Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis.J Cyst Fibros. 2014 May;13(3):311-8. doi: 10.1016/j.jcf.2013.11.004. Epub 2013 Dec 13. J Cyst Fibros. 2014. PMID: 24332997 Free PMC article. Clinical Trial.
-
Intraspecies Signaling between Common Variants of Pseudomonas aeruginosa Increases Production of Quorum-Sensing-Controlled Virulence Factors.mBio. 2020 Aug 25;11(4):e01865-20. doi: 10.1128/mBio.01865-20. mBio. 2020. PMID: 32843558 Free PMC article.
-
Pyoverdine, the Major Siderophore in Pseudomonas aeruginosa, Evades NGAL Recognition.Interdiscip Perspect Infect Dis. 2012;2012:843509. doi: 10.1155/2012/843509. Epub 2012 Sep 2. Interdiscip Perspect Infect Dis. 2012. PMID: 22973307 Free PMC article.
-
Proteomic profiling of Pseudomonas aeruginosa AES-1R, PAO1 and PA14 reveals potential virulence determinants associated with a transmissible cystic fibrosis-associated strain.BMC Microbiol. 2012 Jan 22;12:16. doi: 10.1186/1471-2180-12-16. BMC Microbiol. 2012. PMID: 22264352 Free PMC article.
-
Marine-derived quorum-sensing inhibitory activities enhance the antibacterial efficacy of tobramycin against Pseudomonas aeruginosa.Mar Drugs. 2014 Dec 24;13(1):1-28. doi: 10.3390/md13010001. Mar Drugs. 2014. PMID: 25546516 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical